Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001824293-23-000182
Filing Date
2023-12-20
Accepted
2023-12-20 17:12:21
Documents
4
Period of Report
2023-12-20

Document Format Files

Seq Description Document Type Size
1 PRE 14A specialmeetingproxy_dec2023.htm PRE 14A 178202
2 GRAPHIC image_2.jpg GRAPHIC 19695
3 GRAPHIC screenshot2023-12x18185922a.jpg GRAPHIC 108774
4 GRAPHIC screenshot2023-12x18190025a.jpg GRAPHIC 128657
  Complete submission text file 0001824293-23-000182.txt   533943
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037 (619) 400-1171
GRI BIO, Inc. (Filer) CIK: 0001824293 (see all company filings)

EIN.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-40034 | Film No.: 231502117
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)